Cochlear faces shareholder class action over guidance downgrade
- Cochlear faces a class action lawsuit in the Supreme Court of Victoria following its major FY26 earnings guidance reduction.
- The legal action represents investors who bought shares between Aug. 15, 2025, and April 21, 2026, before the stock experienced a single-day 40% collapse.
- Plaintiffs allege the medical device manufacturer engaged in misleading conduct and breached continuous disclosure rules regarding its profit forecasts.
Hearing implant manufacturer Cochlear (ASX:COH) is facing a class action lawsuit in the Supreme Court of Victoria from shareholders who bought stock between Aug. 15, 2025 and April 21, 2026.
The legal filing follows a major 22 April announcement where the company slashed its full-year underlying net profit expectations from $435-$460 million down to $290-$330 million.
The lawsuit focuses on alleged continuous disclosure failures before the business erased more than $4 billion in market value during a single trading session.
The legal action adds pressure to the manufacturer as it works to recover from regional market disruptions and softer international device sales.
Following the announcement, the Cochlear share price was down at $145.06.
The company maintains an international market presence through its core cochlear implant systems, bone conduction devices, and sound processor technology.
